AQN vs MWH

The deterministic health scores indicate significant concerns, with a Piotroski F-Score of 4/9 signaling borderline financial stability and no available Altman Z-Score limiting distress risk assessment. Despite a recent 1Y price surge of +47.5%, the stock trades at a steep valuation (P/E 91.14 vs sector avg 19.73) while reporting a negative profit margin (-1.11%) and an unsustainable dividend payout ratio (371.43%). However, strong operating metrics like 25.07% operating margin, improving EPS trends (+12.5% YoY), and a 4.06% dividend yield provide some support. The lack of insider activity and mixed analyst sentiment (hold) further justify a cautious stance.

MWH exhibits a stable financial foundation with a Piotroski F-Score of 5/9, but faces a severe valuation disconnect. While the company shows explosive growth (80% YoY Revenue) and an exceptional ROE of 35.28%, it trades at a massive premium compared to its Graham Number ($8.13) and Intrinsic Value ($5.25). The strong analyst consensus (Strong Buy) and forward P/E compression suggest high growth expectations, but the current price of $33.97 is fundamentally unsupported by traditional value metrics.